Ribonucleoside cyclic acetal derivatives for the treatment of RNA-dependent RNA viral infection
Details for Australian Patent Application No. 2006280175 (hide)
International Classifications
Event Publications
6 March 2008 PCT application entered the National Phase
PCT publication WO2007/021610 Priority application(s): WO2007/021610
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
1 September 2011 Application Accepted
Published as AU-B-2006280175
12 January 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006280176-Composite materials including high modulus polyolefin fibers and method of making same
2006280168-Methods and compositions for soothing oral and nasal tissues
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser